Display options
Share it on

Pharmacol Res Perspect. 2015 Oct;3(5):e00188. doi: 10.1002/prp2.188. Epub 2015 Oct 02.

Microparticle of drug and nanoparticle: a biosynthetic route.

Pharmacology research & perspectives

Sounik Sarkar, Anjan Kr Dasgupta

Affiliations

  1. Department of Biochemistry and Centre of Excellence in Biomedical Engineering and Systems Biology, University of Calcutta 35 Ballygunge Circular Road, Kolkata, 700019, India.

PMID: 26516592 PMCID: PMC4618651 DOI: 10.1002/prp2.188

Abstract

Microparticles (MPs) have great potentiality in material science- based applications. Their use in biology is however limited to clinics and has rarely been exploited in the pharmaceutical context. Unlike nanoparticles (NPs), they are amenable to routine detection by flow cytometry and confocal microscopy. Though MPs can constitute a wide variety of materials, including ceramics, glass, polymers, and metals and can be synthesized by chemical process but wet processes for the preparation of microparticles have rarely been attemped. In this paper, a thrombotic route is shown to successfully generate biocompatible MP of a model anticancer drug (doxorubicin hydrochloride). Synthesis of MPs from platelets and drug loading in to these MPs was confirmed by flow cytometry and confocal microscopy. Human cervical cancer cell line (HeLa) was treated with these drug-loaded MPs to investigate whether the loaded MPs have the capacity to deliver drug to the cancer cells. In addition, Magnetic force microscopy was used to detect the preparation of MPs loaded with magnetic NPs. The efficiency of the drug-loaded MPs in inducing cytotoxicity in cancer cell line, shown to be significantly higher than the free drug itself. The drug-loaded MP is shown to have a much higher cytotoxic propensity than the free drug applied at comparable doses. The thrombotic approach can also be applied to synthesize MP containing NPs which in turn can lead to generate a wide variety of new biocompatible materials.

Keywords: Doxorubicin; drug delivery; microparticle; nanoparticle; platelet

References

  1. Toxicology. 2008 Apr 3;246(1):24-33 - PubMed
  2. Biomed Res Int. 2014;2014:756327 - PubMed
  3. Small. 2015 Jun 3;11(21):2571-81 - PubMed
  4. J Control Release. 2001 Oct 19;76(3):239-54 - PubMed
  5. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2892-7 - PubMed
  6. Tex Heart Inst J. 2009;36(2):134-9 - PubMed
  7. Thromb Haemost. 2001 Apr;85(4):639-46 - PubMed
  8. J Immunol Methods. 2001 Aug 1;254(1-2):109-18 - PubMed
  9. Pharm Res. 2013 Nov;30(11):2785-94 - PubMed
  10. Drug Discov Today. 2008 Jan;13(1-2):1-13 - PubMed
  11. Discov Med. 2009 Dec;8(43):237-41 - PubMed
  12. Biochem J. 2004 Jan 1;377(Pt 1):159-69 - PubMed
  13. Vox Sang. 2003 Oct;85(3):240-5 - PubMed
  14. Thromb Haemost. 2009 Mar;101(3):439-51 - PubMed
  15. J Clin Invest. 2005 Dec;115(12):3348-54 - PubMed
  16. J Thromb Haemost. 2008 Sep;6(9):1517-24 - PubMed
  17. J Control Release. 1999 May 20;59(2):123-32 - PubMed
  18. Clin Gastroenterol Hepatol. 2008 Mar;6(3):290-7 - PubMed
  19. J Microencapsul. 2010 May;27(3):187-97 - PubMed
  20. J Thromb Haemost. 2011 Jun;9(6):1216-24 - PubMed
  21. Thromb Haemost. 2001 May;85(5):810-20 - PubMed
  22. Asian-Australas J Anim Sci. 2015 Feb;28(2):290-302 - PubMed
  23. Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):5-18 - PubMed
  24. Trends Cell Biol. 2009 Feb;19(2):43-51 - PubMed
  25. Crit Rev Oncol Hematol. 1999 Apr;30(2):111-42 - PubMed
  26. Occup Ther Health Care. 2013 Jul;27(3):228-37 - PubMed
  27. Semin Oncol. 2014 Jun;41(3):346-58 - PubMed
  28. Blood. 2011 Jan 27;117(4):e39-48 - PubMed
  29. Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1035-41 - PubMed

Publication Types